Fresenius Medical Care AG (XTER:FME) Beta: 0.9552 (As of Jun. 24, 2026)


XTER:FME Fresenius Medical Care AG XTER:FME
70 GF Score
Price €41.55
GF Value €41.29
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Beta?

Fresenius Medical Care AG XTER:FME +0.73% 70 Beta is 0.9552 as of Jun. 24, 2026. GuruFocus rates XTER:FME with a GF Score™ of 70/100 and a GF Value™ of €41.29 (Fairly Valued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-24), Fresenius Medical Care AG's Beta is 0.9552.


Fresenius Medical Care AG  (XTER:FME) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Fresenius Medical Care AG Beta Related Terms


Fresenius Medical Care AG Beta Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Beta Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.71 0.62 1.17 1.22 0.00

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 1.31 1.22 0.00 1.00

XTER:FME vs HCA, THC, DVA: Beta Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Beta vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Beta distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Beta falls into.


XTER:FME
70GF Score
Fresenius Medical Care AG XTER:FME
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.9552 mean?
Fresenius Medical Care AG (XTER:FME) has a Beta of 0.9552 as of Jun. 24, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's Beta too high?
Fresenius Medical Care AG's current Beta is 0.9552. Overall, Fresenius Medical Care AG has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Beta compare to HCA and THC?
Fresenius Medical Care AG's Beta of 0.9552 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Healthcare Providers & Services company?
A good Beta depends on the Healthcare Providers & Services industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Beta is 0.9552. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (XTER:FME) is currently considered Fairly Valued. The stock's GF Value™ is €41.29, compared to a current price of €41.55 — trading 0.6% above its estimated fair value. The current Beta is 0.9552. Fresenius Medical Care AG's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Fresenius Medical Care AG (XTER:FME), the current Beta is 0.9552 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (XTER:FME) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be overvalued. The current stock price of €41.55 is trading 0.6% above its estimated GF Value™ of €41.29. GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.

Key valuation signals for XTER:FME:

  • Beta: 0.9552
  • GF Value™: €41.29 vs. price of €41.55 (0.6% above fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the XTER:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
70GF Score

Get the complete analysis for XTER:FME

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.55
Price
€41.29
GF Value